Index RUT
P/E -
EPS (ttm) -1.44
Insider Own 6.67%
Shs Outstand 39.17M
Perf Week -3.02%
Market Cap 717.59M
Forward P/E -
EPS next Y -1.30
Insider Trans -0.78%
Shs Float 36.56M
Perf Month 3.56%
Income -55.74M
PEG -
EPS next Q -0.40
Inst Own 104.57%
Short Float 10.18%
Perf Quarter 49.19%
Sales 177.13M
P/S 4.05
EPS this Y 3.26%
Inst Trans -0.57%
Short Ratio 4.25
Perf Half Y 20.37%
Book/sh 3.86
P/B 4.75
EPS next Y 6.75%
ROA -20.84%
Short Interest 3.72M
Perf Year -52.60%
Cash/sh 4.63
P/C 3.95
EPS next 5Y 16.20%
ROE -35.39%
52W Range 6.08 - 46.57
Perf YTD 49.31%
Dividend Est. 0.13 (0.70%)
P/FCF -
EPS past 5Y -3.21%
ROI -23.81%
52W High -60.66%
Beta 1.48
Dividend TTM -
Quick Ratio 6.97
Sales past 5Y 40.27%
Gross Margin 71.75%
52W Low 201.32%
ATR (14) 0.96
Dividend Ex-Date -
Current Ratio 7.95
EPS Y/Y TTM 6.80%
Oper. Margin -33.46%
RSI (14) 58.31
Volatility 4.50% 6.57%
Employees 474
Debt/Eq 0.56
Sales Y/Y TTM 27.77%
Profit Margin -31.47%
Recom 2.30
Target Price 20.00
Option/Short Yes / Yes
LT Debt/Eq 0.55
EPS Q/Q 0.66%
Payout -
Rel Volume 1.33
Prev Close 18.71
Sales Surprise 12.73%
EPS Surprise 21.56%
Sales Q/Q 17.97%
Earnings Feb 28 AMC
Avg Volume 874.84K
Price 18.32
SMA20 6.27%
SMA50 11.09%
SMA200 10.70%
Trades
Volume 1,164,058
Change -2.08%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Upgrade
Argus
Hold → Buy
$24
Jan-19-24 Upgrade
Stifel
Hold → Buy
$9 → $20
Jan-03-24 Initiated
Lake Street
Buy
$20
Oct-24-23 Upgrade
Wolfe Research
Underperform → Peer Perform
Oct-11-23 Downgrade
Stifel
Buy → Hold
$45 → $12
Oct-11-23 Downgrade
CL King
Buy → Neutral
Oct-11-23 Downgrade
Citigroup
Buy → Sell
$35 → $8
Oct-11-23 Downgrade
B. Riley Securities
Buy → Neutral
$54 → $14
Sep-21-23 Downgrade
Argus
Buy → Hold
Sep-06-23 Initiated
Oppenheimer
Outperform
$30
Jul-12-23 Downgrade
JP Morgan
Overweight → Neutral
$50 → $28
Jul-12-23 Downgrade
BofA Securities
Buy → Underperform
$51 → $28
May-23-23 Initiated
CL King
Buy
$47
May-15-23 Downgrade
Wolfe Research
Peer Perform → Underperform
$27
Apr-03-23 Upgrade
Citigroup
Neutral → Buy
$50
Mar-31-23 Initiated
B. Riley Securities
Buy
$58
Mar-10-23 Upgrade
Citigroup
Sell → Neutral
$50
Feb-07-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Nov-22-22 Initiated
BofA Securities
Buy
$60
Jul-11-22 Downgrade
Citigroup
Neutral → Sell
$33
Show Previous Ratings
Mar-22-24 12:00PM
Mar-07-24 09:00PM
07:52AM
Mar-05-24 09:00AM
Feb-29-24 10:50AM
06:38AM
Loading…
06:38AM
(Thomson Reuters StreetEvents)
Feb-28-24 06:20PM
05:18PM
(Associated Press Finance)
04:40PM
04:05PM
Feb-07-24 04:30PM
Jan-22-24 07:27AM
Dec-26-23 04:40AM
Dec-21-23 11:08PM
Dec-20-23 04:30PM
04:09AM
Loading…
Dec-08-23 04:09AM
Nov-21-23 05:56PM
Nov-13-23 04:07PM
Nov-10-23 01:19PM
Nov-09-23 01:50AM
Nov-08-23 06:42PM
05:05PM
(Associated Press Finance)
04:05PM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 02:02PM
Oct-26-23 04:30PM
Oct-25-23 10:25AM
Oct-16-23 11:29AM
Oct-11-23 06:16PM
12:07PM
Loading…
12:07PM
12:06PM
11:30AM
11:01AM
08:08AM
03:49AM
Oct-10-23 04:20PM
04:20PM
Sep-21-23 10:06AM
Sep-04-23 04:30PM
Aug-11-23 06:19AM
Aug-03-23 04:30PM
Aug-02-23 10:21AM
09:03AM
(Thomson Reuters StreetEvents)
Aug-01-23 05:35PM
04:30PM
04:05PM
Jul-13-23 02:25AM
Jul-12-23 12:35PM
08:57AM
Jul-11-23 04:30PM
Jun-30-23 08:31AM
May-22-23 07:09AM
06:54AM
May-16-23 03:28AM
May-09-23 06:25PM
05:18PM
04:05PM
May-07-23 08:54AM
May-05-23 09:00AM
May-04-23 04:30PM
Apr-26-23 04:30PM
Apr-18-23 04:30PM
Mar-31-23 10:36AM
08:11AM
Mar-27-23 09:54AM
Mar-02-23 08:29PM
Mar-01-23 07:52AM
(Thomson Reuters StreetEvents) -9.76%
Feb-28-23 08:05PM
04:05PM
Feb-07-23 09:00AM
Jan-23-23 12:00PM
Jan-09-23 07:20AM
07:05AM
Dec-30-22 12:46AM
Dec-28-22 04:30PM
Dec-22-22 11:47AM
Dec-12-22 09:15AM
Dec-05-22 12:00PM
Nov-10-22 07:36AM
Nov-08-22 07:35PM
04:05PM
Nov-03-22 04:30PM
Nov-01-22 12:35PM
Oct-25-22 04:30PM
Oct-19-22 01:27PM
Oct-18-22 07:46PM
Oct-17-22 08:03PM
04:25PM
12:53PM
Sep-29-22 07:41AM
Sep-28-22 02:25PM
(Investor's Business Daily) +9.33%
Sep-07-22 04:15PM
Aug-30-22 04:15PM
Jul-27-22 09:31AM
Jul-26-22 05:35PM
04:05PM
Jul-22-22 01:26PM
(Investor's Business Daily)
Jul-12-22 04:15PM
07:07AM
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ballinger Kevin J. Director Mar 05 '24 Buy 16.99 11,700 198,783 17,807 Mar 07 06:01 AM Buchanan Lucas W. COO/CFO Mar 05 '24 Sale 17.17 9,877 169,578 500,925 Mar 05 07:51 PM Davis Andrew S. Chief Commercial Officer Mar 05 '24 Sale 17.17 5,481 94,103 287,773 Mar 05 06:25 PM Ruedy Richard EVPClin&Reg.Affairs&QA Mar 05 '24 Sale 17.17 3,800 65,242 205,711 Mar 05 07:50 PM Jones Marie L. VP, Finance and CAO Mar 05 '24 Sale 17.17 2,602 44,674 76,894 Mar 05 06:20 PM Klemz Kevin M EVP/Chief Legal Officer/Sec. Mar 05 '24 Sale 17.17 2,497 42,871 165,194 Mar 05 06:16 PM Ruedy Richard EVPClin&Reg.Affairs&QA Feb 29 '24 Sale 22.25 3,000 66,750 170,837 Mar 04 06:19 PM Jones Marie L. CAO and VP, Finance Oct 27 '23 Sale 6.61 656 4,334 54,941 Oct 30 06:53 PM Buchanan Lucas W. COO/CFO Oct 04 '23 Sale 15.22 2,662 40,524 435,848 Oct 06 06:28 PM Klemz Kevin M EVP/Chief Legal Officer/Sec. Aug 17 '23 Sale 20.11 1,539 30,942 38,797 Aug 18 08:16 PM Davis Andrew S. Chief Commercial Officer Aug 03 '23 Sale 22.13 6,587 145,797 109,534 Aug 04 05:31 PM Buchanan Lucas W. COO/CFO Jul 28 '23 Option Exercise 5.42 9,643 52,229 215,725 Jul 31 05:44 PM Jones Marie L. CAO and VP, Finance Jul 20 '23 Option Exercise 6.11 2,000 12,220 48,002 Jul 21 06:24 PM Rogers Erica J. President and CEO Jul 11 '23 Option Exercise 1.60 1,000 1,600 270,639 Jul 13 06:34 PM Rogers Erica J. President and CEO Jul 11 '23 Sale 31.56 1,000 31,560 269,639 Jul 13 06:34 PM Davis Andrew S. Chief Commercial Officer Jul 06 '23 Sale 30.79 69 2,124 115,614 Jul 10 05:39 PM Rogers Erica J. President and CEO Jun 12 '23 Option Exercise 1.60 1,000 1,600 270,639 Jun 13 08:13 PM Rogers Erica J. President and CEO Jun 12 '23 Sale 32.13 1,000 32,130 269,639 Jun 13 08:13 PM Rogers Erica J. President and CEO May 11 '23 Option Exercise 1.60 3,000 4,800 272,132 May 12 09:37 PM Rogers Erica J. President and CEO May 11 '23 Sale 35.51 3,000 106,530 269,132 May 12 09:37 PM Davis Andrew S. Chief Commercial Officer May 01 '23 Option Exercise 5.90 6,753 39,845 122,436 May 03 06:39 PM Davis Andrew S. Chief Commercial Officer May 01 '23 Sale 44.51 6,753 300,593 115,683 May 03 06:39 PM WEATHERMAN ELIZABETH H Director Apr 17 '23 Sale 41.91 5,000 209,550 144,454 Apr 19 06:14 PM Rogers Erica J. President and CEO Apr 11 '23 Option Exercise 1.60 6,000 9,600 275,132 Apr 12 05:29 PM Rogers Erica J. President and CEO Apr 11 '23 Sale 39.77 6,000 238,635 269,132 Apr 12 05:29 PM Davis Andrew S. Chief Commercial Officer Apr 03 '23 Option Exercise 4.79 6,753 32,372 122,436 Apr 05 05:19 PM Davis Andrew S. Chief Commercial Officer Apr 03 '23 Sale 39.42 6,753 266,203 115,683 Apr 05 05:19 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite